Lawmakers Probe FDA Over Handling Of Cordis Warning Letter

The House Energy and Commerce Committee sent letters to FDA and Johnson & Johnson Aug. 13 requesting documents as part of an inquiry into FDA's Office of Regulatory Affairs

More from Archive

More from Medtech Insight